NCT05387681View on ClinicalTrials.gov

Preoperative Short Course Radiotherapy With Envafolimab, Endostatin and SOX Regimen in Locally Advanced Gastric

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 30, 2022

Primary Completion Date

July 30, 2023

Study Completion Date

December 30, 2025

Conditions
Gastric/Gastroesophageal Junction AdenocarcinomaRadiotherapyImmunotherapy
Interventions
DRUG

Envafolimab

short course radiotherapy ：5\*5Gy (25Gy/5F) ； Envafolimab：300 mg, subcutaneously, D1, Q3W; Endostatin ：210mg (14 doses), CIV continuously pumped for 72h, Q3W; chemotherapy：SOX regimen

All Listed Sponsors
lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

NCT05387681 - Preoperative Short Course Radiotherapy With Envafolimab, Endostatin and SOX Regimen in Locally Advanced Gastric | Biotech Hunter | Biotech Hunter